Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. - Wikidata - wikimedia - TriplyDB

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q34120159

about

Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes Molecular and physiological effects of overexpressing striated muscle beta-tropomyosin in the adult murine heart Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update.Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy.Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.Counselling issues in familial hypertrophic cardiomyopathy.Genetic causes of human heart failure.β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations The molecular genetic basis for hypertrophic cardiomyopathy.Mutation of the myosin converter domain alters cross-bridge elasticity.Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy.Molecular medicine in the 21st century.Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation Modifier genes for hypertrophic cardiomyopathy VIP gene deletion in mice causes cardiomyopathy associated with upregulation of heart failure genes.Molecular biology of heart disease.Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy Alternative exon 9-encoded relay domains affect more than one communication pathway in the Drosophila myosin head Hypertrophic cardiomyopathy: from gene defect to clinical disease.Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.Unequal allelic expression of wild-type and mutated β-myosin in familial hypertrophic cardiomyopathy.Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain Genetic basis of hypertrophic cardiomyopathy.Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy.Cardiac arrest and hypertrophic cardiomyopathy. Role of the implantable defibrillator.Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.Contemporary treatment of hypertrophic cardiomyopathy Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations.Genetic biomarkers in hypertrophic cardiomyopathy.

P2860

Q24316488-F8967A27-97E9-48B0-B4E3-75A905B60781 Q28075470-9A8BEAB7-4523-46BA-B94C-FCC7B3A4DA73 Q28248327-D3BB2326-9845-4B30-883A-20DE5D52A64C Q28271303-11799882-3E15-49EE-AF64-725F6F76BB8C Q28283579-E07DCEE5-BD23-4DCE-AC17-62DDE7DB3676 Q28508653-AF182FE9-0DBE-48E8-A1D7-C371996305D9 Q30371882-8C2E6604-772D-48C7-8D8B-FF61BA81DCBE Q30838224-AA55C7A6-213D-4A2D-A4D8-3ABF0217788B Q33158326-E0F68418-51D7-4051-BFBC-A23DA5617DCC Q33167938-EA13A868-61CC-4B6D-863B-D1CE135507AE Q33680307-051954F9-78EB-4DF1-B24B-3F2290329AA8 Q33683773-C7AF7BB4-DF52-4050-B059-0764D28EA587 Q33864019-DA4DDF3B-373E-4742-8182-62E220FA64B9 Q33939892-FB5FF3FC-3AE3-4905-A4F3-8BD41D912262 Q34019053-A2CEBC9B-B475-46C4-A985-EA4C6B5CF57A Q34021080-649CC8A3-2D9F-4773-9F56-794E746DC721 Q34028344-97A83061-1541-4769-9348-0ECF0C824654 Q34322422-AEC0B7C3-28E8-464B-B1C0-43D97A3AFFC2 Q34474908-523666BC-2E42-431A-81AC-B899445ABCC9 Q34627120-95F526CA-DBF7-4F0D-86DB-F0F637F9A4A3 Q34627221-631E78CE-C04E-40ED-B4C4-BABB48070F3C Q34641881-E18767A3-7FDE-4ECF-945C-4813039F420C Q34734925-8471A4AD-A2CF-4056-AA99-75A2F2C7DE27 Q34863040-B2020733-1D8E-439C-B282-E41959DEDDBF Q34999606-970129D5-3BC9-46F5-80AC-45A08DA9EB9E Q35059426-EC286BD4-B33E-40EA-B91C-B43E33BD2DA2 Q35087752-480D80C4-DD9A-49D8-96A5-45686CA4FE67 Q35369864-7D761BF9-44C0-4061-8CEC-79574E647711 Q35587444-9ABA2E8D-1029-42AB-9001-711C3F3D8211 Q35792948-F39CC244-C6A7-4B4E-9985-20F06CF14D0F Q36686074-F712E411-2FDB-40F7-ADE9-0E73F87A051E Q36847169-A278BC8A-6E91-4E8E-BE88-327AF2C097EA Q36888495-792A95DC-E830-4017-B0EA-65C4307E318B Q36903712-67453690-70BE-46B6-9DDD-8F1DB822D425 Q37227838-7EBCC50B-7D88-440B-80B0-9AD7958A25CB Q37255253-26A6D31B-A019-4A77-8621-8C7E418EBA87 Q37362212-045950BB-D25B-4815-B5A0-40D787CAF8D0 Q37603719-1B47B3BF-BB32-42AF-808A-85CBA195ED36 Q37725295-2D5ABB2A-79F1-4CA8-A6FC-4D4FB7DC1FA1 Q38125765-493E1F47-867A-4277-B31E-737C61BFD8B4

P2860

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q34120159

description

1994 nî lūn-bûn

@nan

1994 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1994 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

name

Prognostic implications of nov ...... l hypertrophic cardiomyopathy.

@ast

Prognostic implications of nov ...... l hypertrophic cardiomyopathy.

@en

Prognostic implications of nov ...... l hypertrophic cardiomyopathy.

@nl

type

label

Prognostic implications of nov ...... l hypertrophic cardiomyopathy.

@ast

Prognostic implications of nov ...... l hypertrophic cardiomyopathy.

@en

Prognostic implications of nov ...... l hypertrophic cardiomyopathy.

@nl

prefLabel

Prognostic implications of nov ...... l hypertrophic cardiomyopathy.

@ast

Prognostic implications of nov ...... l hypertrophic cardiomyopathy.

@en

Prognostic implications of nov ...... l hypertrophic cardiomyopathy.

@nl

P1433

Q34120159-F30482F0-BFB2-4434-9305-96F3D6E5E04C

P1476

Q34120159-8075594A-290C-47BC-A382-3AA7A1025F57

P2093

Q34120159-07F8ADE1-79C8-46BF-A07E-2325E40181AF

Q34120159-193702FB-D4D9-4296-A01F-6822C5D6D9D8

Q34120159-51688BC7-5F88-4516-9DD4-CB609FE85B54

Q34120159-54A76A44-2A4A-425B-A1A0-ACD0BA6957B1

Q34120159-5C92B25A-1A7A-44B2-A7F5-AA164CF9F076

Q34120159-5F8219C6-9C78-4C04-B522-69551584C165

Q34120159-72C8CE7C-DF38-4819-B63C-94E618A13E58

Q34120159-B44D33C6-9424-43A9-B905-A6D136484E8A

Q34120159-F58776B4-1E9E-4E07-B20B-D74B8A86BD87

P2860

Q34120159-0BC134E8-18EC-4E82-952E-EB7EAD9861D2

Q34120159-208A93A6-9010-4142-BB9A-D1052E2F39D1

Q34120159-20E8A513-21FE-4143-A234-886AE7C40249

Q34120159-2321706C-3EEF-4821-A93B-4E1455AFDDEC

Q34120159-2D0551BE-1CE4-4A28-810E-BDCF0074E3CD

Q34120159-2E3C69CE-A635-42C8-936B-5EE9DACFB28D

Q34120159-442E567F-9178-49A3-9332-6542FE030607

Q34120159-4ECCAC45-DDC8-4CFC-975D-A6F34C12BEAD

Q34120159-5875597E-D130-48CE-940A-23ADC7A9A74D

Q34120159-6EF15219-CC2A-49C9-A4AC-72D55A499046

P304

Q34120159-50813D86-3828-43F3-B9F5-DC703BD7893C

P31

Q34120159-C527A04F-DB67-4DE5-8831-25A595B17187

P356

Q34120159-8FF87C8C-6125-432A-835A-CC7DB8F8ADE0

P407

Q34120159-2592AA68-03FB-4FEF-872A-540C7DA86922

P433

Q34120159-EEEBB0E7-08A6-466A-B1E8-4D12D1CE2D35

P478

Q34120159-3F290F80-0AA0-498D-939B-BFF2F73026D3

P50

Q34120159-3504E1EF-3E2D-4454-AEB3-9ED840DAC54F

P577

Q34120159-E81FFDF3-5CC5-43BD-A9D0-E4EE3020916F

P5875

Q34120159-29D039A8-2EC0-4173-9868-82FA98EA326B

P698

Q34120159-FAC66D8B-086C-4C7C-AC86-067AC6AD3AFD

P932

Q34120159-8326D402-ABA1-44B4-A086-42DC3CFCB2CF

P356

P1433

Journal of Clinical Investigation

P1476

Prognostic implications of nov ...... l hypertrophic cardiomyopathy.

@en

P2093

C Vecchio

http://www.w3.org/2001/XMLSchema#string

G Greve

http://www.w3.org/2001/XMLSchema#string

H Shono

http://www.w3.org/2001/XMLSchema#string

H Tanaka

http://www.w3.org/2001/XMLSchema#string

L Thierfelder

http://www.w3.org/2001/XMLSchema#string

R Anan

http://www.w3.org/2001/XMLSchema#string

S Nakao

http://www.w3.org/2001/XMLSchema#string

S Solomon

http://www.w3.org/2001/XMLSchema#string

W J McKenna

http://www.w3.org/2001/XMLSchema#string

P2860

Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy

Three-dimensional structure of myosin subfragment-1: a molecular motor

The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

Structure of the actin-myosin complex and its implications for muscle contraction

Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11

Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations.

Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy.

Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy

P304

280-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI116957

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P50

Hugh Christian Watkins

P577

1994-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14916092

http://www.w3.org/2001/XMLSchema#string

P698

8282798

http://www.w3.org/2001/XMLSchema#string

P932

293763

http://www.w3.org/2001/XMLSchema#string